All Updates

A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients had out-of-pocket costs for follow-up breast cancer diagnostic tests in 2023.

Washington, D.C. – As one of the leading patient advocacy groups that pushed for the passage of the Patient Protection and Affordable Care Act (ACA), the American Cancer Society Cancer Action Network (ACS CAN) is celebrating Sunday’s 15th anniversary of the historic law by highlighting its positive impacts and calling

Survivors and oncology professionals share their stories with lawmakers to underscore the importance of insurance coverage of cutting-edge biomarker testing

Insurance coverage of biomarker testing will reduce health disparities for cancer patients & improve outcomes across broad spectrum of serious disease

Last week, the Senate and House voted to advance Senate Bill 773 and House Bill 1246, legislation which seeks to create more stability for patients by curbing an unfair insurance practice that makes critical medication more expensive and access unpredictable. The passage of each bill in their respective chambers, which now await concurrence voting, came on the heels of the American Cancer Society Cancer Action Network’s (ACS CAN) annual Cancer Action Day when cancer survivors, patient advocates and medical professionals traveled to Annapolis to discuss the importance of this legislation in ensuring access to lifesaving prescription drugs. Advocates are hopeful that lawmakers see the bills’ momentum as a call to action to take the final steps to pass and enact the necessary reforms.

This afternoon, the New York State Senate unanimously passed legislation that would eliminate cost-sharing for lung cancer screenings and follow-up tests for all eligible New Yorkers insured through a state-regulated health plan, including Medicaid. Senate Bill 2000, sponsored by Senator Joseph Addabbo, received sweeping, bipartisan support and the backing of a coalition of patient advocates, medical leaders and public health organizations.

This afternoon, the New York State Senate unanimously passed legislation that would eliminate cost-sharing for lung cancer screenings and follow-up tests for all eligible New Yorkers insured through a state-regulated health plan, including Medicaid. Senate Bill 2000, sponsored by Senator Joseph Addabbo, received sweeping, bipartisan support and the backing of a coalition of patient advocates, medical leaders and public health organizations.

ATLANTA, March 18, 2025 — Short-term limited duration (STLD) insurance plans do not provide comprehensive coverage and can leave patients who are diagnosed with a serious disease like cancer with catastrophic costs. In a new, large national study published today in the Journal of the American Medical Association

Volunteer advocates, including cancer survivors, patients, and caregivers from across Hawaii convened at the state capitol Tuesday for ‘Cancer Action Day,’ an event hosted annually by the American Cancer Society Cancer Action Network (ACS CAN). During meetings with lawmakers, volunteers expressed desire for leaders to support policies that aim to